Drug Shortage Report for TEVA-PANTOPRAZOLE

Last updated on 2021-10-14 History
Report ID 88216
Drug Identification Number 02285487
Brand name TEVA-PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-30
Estimated end date
Actual end date 2021-10-12
Shortage status Resolved
Updated date 2021-10-14
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-10-14 French Compare
v3 2021-10-14 English Compare
v2 2019-07-02 French Compare
v1 2019-07-02 English Compare